BackATAI Life Sciences N.V. Overview
ATAI Life Sciences N.V.

ATAI Life Sciences N.V. Target Price

Analysts' average 12-month price target for ATAI Life Sciences N.V. is $9.2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.35

Average Target Price

$9.2425.7% upside

6 analysts in the last 4 months

High: $17 | Low: $7.45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-12Deutsche BankDavid Hoang$88.8% upsideOpen
2026-07-20H.C. WainwrightPatrick Trucchio$7.52% upsideOpen
2026-07-20Berenberg Bank$7.451.4% upsideOpen
2026-07-16Jefferies$7.52% upsideOpen
2026-07-16Canaccord Genuity$88.8% upsideOpen
2026-07-07Canaccord Genuity$17131.3% upsideOpen
2026-04-20Canaccord GenuitySumant Kulkarni$15104.1% upsideOpen
2026-03-27Deutsche Bank$1263.3% upsideOpen
2026-03-06JefferiesAndrew Tsai$1036.1% upsideOpen
2026-01-20Guggenheim$1149.7% upsideOpen
2025-10-22Canaccord Genuity$1490.5% upsideOpen
2025-10-13Needham$1263.3% upsideOpen
2025-05-20JefferiesAndrew Tsai$532% downsideOpen
2024-04-03Maxim GroupJason McCarthy$618.4% downsideOpen

ATAI Life Sciences N.V. (ATAI) FAQ

ATAI Life Sciences N.V. (ATAI) currently reports a target price of $9.2. Use the charts on this page to explore ATAI Life Sciences N.V.'s target price history and peer comparisons.

Analysts' average 12-month price target for ATAI Life Sciences N.V. is $9.2, about 25.7% upside from the current share price of $7.35. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $9.2, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ATAI Life Sciences N.V., and consider following ATAI for alerts when major investors trade the stock.

ATAI Life Sciences N.V. is classified in the Healthcare sector. On target price, it currently shows $9.2. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATAI with unrelated industries.